585 related articles for article (PubMed ID: 9246749)
1. Synthesis and antitumor activity of 9-acyloxyellipticines.
Harada N; Ozaki K; Oda K; Nakanishi N; Ohashi M; Hashiyama T; Tsujihara K
Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1156-62. PubMed ID: 9246749
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of quaternary salts of 2-(2'-oxoalkoxy)-9-hydroxyellipticines.
Harada N; Kawaguchi T; Inoue I; Ohashi M; Oda K; Hashiyama T; Tsujihara K
Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):134-7. PubMed ID: 9023975
[TBL] [Abstract][Full Text] [Related]
3. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G
J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
Narita T; Yaguchi S; Komatsu T; Takase M; Hoshino A; Inaba M; Tsukagoshi S
Cancer Chemother Pharmacol; 1990; 26(3):193-7. PubMed ID: 2357766
[TBL] [Abstract][Full Text] [Related]
7. Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30.
Rose WC; Basler GA; Trail PA; Saulnier M; Crosswell AR; Casazza AM
Invest New Drugs; 1990; 8 Suppl 1():S25-32. PubMed ID: 2380014
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 6-(9-hydroxy-5-methyl (and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazol-1-yl)picolinic amides as new olivacine derivatives.
Landras C; Jasztold-Howorko R; Pierré A; Léonce S; Guilbaud N; Kraus-Berthier L; Guillonneau C; Rolland Y; Atassi G; Bisagni E
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2169-72. PubMed ID: 8945783
[TBL] [Abstract][Full Text] [Related]
9. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones.
Kuśnierczyk H; Chołody WM; Paradziej-Lukowicz J; Radzikowski C; Konopa J
Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):415-23. PubMed ID: 8572901
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
[TBL] [Abstract][Full Text] [Related]
11. 1-Amino-substituted 4-methyl-5H-pyrido[4,3-b]indoles (gamma-carbolines) as tricyclic analogues of ellipticines: a new class of antineoplastic agents.
Bisagni E; Nguyen CH; Pierré A; Pépin O; de Cointet P; Gros P
J Med Chem; 1988 Feb; 31(2):398-405. PubMed ID: 3339609
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activities of water-soluble benzoylphenylureas.
Okada H; Kato M; Koyanagi T; Mizuno K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):430-3. PubMed ID: 10212393
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands.
Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
J Pharm Sci; 1990 Aug; 79(8):750-3. PubMed ID: 2231341
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
Burres NS; Sazesh S; Gunawardana GP; Clement JJ
Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological properties of some 6H-pyrido[4,3-b]carbazoles.
Archer S; Ross BS; Pica-Mattoccia L; Cioli D
J Med Chem; 1987 Jul; 30(7):1204-10. PubMed ID: 3599025
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate.
Wang Y; Li L; Jiang W; Larrick JW
Bioorg Med Chem; 2005 Oct; 13(19):5592-9. PubMed ID: 16084097
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new 1-phenyl-6H-pyrido[4,3-b]carbazole derivatives with potential cytostatic activity.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Materek P; Wietrzyk J
Acta Pol Pharm; 2011; 68(1):31-7. PubMed ID: 21485699
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
